Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398] Technology appraisal guidance TBC COLOFIT algorithm to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results